tradingkey.logo
tradingkey.logo
Suchen

Elanco Animal Health Inc

ELAN
Zur Watchlist hinzufügen
24.086USD
+0.126+0.53%
Trading geöffnet ETKurse um 15 Minuten verzögert
11.97BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Elanco Animal Health Inc Unternehmen

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.

Elanco Animal Health Inc Informationen

BörsenkürzelELAN
Name des UnternehmensElanco Animal Health Inc
IPO-datumSep 20, 2018
CEOSimmons (Jeffrey N)
Anzahl der mitarbeiter9000
WertpapierartOrdinary Share
GeschäftsjahresendeSep 20
Addresse450 Elanco Circle
StadtINDIANAPOLIS
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl46221
Telefon18773526261
Websitehttps://www.elanco.com/
BörsenkürzelELAN
IPO-datumSep 20, 2018
CEOSimmons (Jeffrey N)

Führungskräfte von Elanco Animal Health Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
101.69K
+16.59%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
94.39K
+4.96%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
83.83K
+35.69%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
71.18K
+12.12%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Elanco Animal Health Inc?

Die fünf größten Anteilseigner von Elanco Animal Health Inc sind: Mr. Jeffrey N. (Jeff) Simmons

Wie viele Institutionen halten Anteile an Elanco Animal Health Inc (ELAN)?

Mit Stand vom 2026Q1 halten 950 Institutionen Anteile an Elanco Animal Health Inc, mit einem Gesamtmarktwert von etwa 549.30M, was 109.98% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -60070109.00 gestiegen.

Was ist die größte Einnahmequelle von Elanco Animal Health Inc?

Am 2026Q1 erzielte das Geschäft mit Farm Animal für Elanco Animal Health Inc den höchsten Umsatz in Höhe von 2.36B, was 50.10% des Gesamtumsatzes entspricht.
KeyAI